What Are the Most Common Side Effects of Semaglutide and Tirzepatide?

By the clinical team at HRT House | Hormone & Weight Loss Specialists

Side effects are one of the first things people ask about when considering GLP-1 therapy — and rightly so. You deserve honest, complete information before starting any medication. The good news is that the most common side effects of Semaglutide and Tirzepatide are well understood, generally manageable, and for most patients significantly diminish as the body adjusts to treatment. Here is what you actually need to know.

The Most Common Side Effects

Nausea is the most commonly reported side effect, affecting approximately 40 to 50% of patients, particularly during the dose escalation phase. It is typically mild to moderate, occurs most often after meals or with certain foods, and diminishes significantly once a stable maintenance dose is reached. For most patients, it resolves within 4 to 8 weeks.

Reduced appetite is listed as a side effect but is also the primary mechanism of action. For most patients, this is a welcome effect. However, some patients — particularly early in treatment — experience appetite reduction so significant that they must be intentional about eating enough protein and nutrients.

Gastrointestinal discomfort — including bloating, constipation, diarrhoea, and acid reflux — affects a meaningful percentage of patients. Slowing gastric emptying (one of the core mechanisms of GLP-1 therapy) can back up digestion and cause these symptoms, particularly in patients who already have GI sensitivity.

Fatigue in the first few weeks is reported by some patients and is typically transient, often related to reduced caloric intake rather than a direct drug effect.

Tirzepatide vs Semaglutide: Does One Cause More Side Effects?

In head-to-head comparisons, Tirzepatide tends to produce somewhat more pronounced GI side effects during dose escalation — likely because its dual GIP and GLP-1 mechanism has a stronger overall effect on gastric motility. However, at maintenance doses, the profiles are broadly similar, and individual tolerance varies significantly.

Patients with pre-existing GI conditions — gastroparesis, inflammatory bowel disease, or significant acid reflux — should discuss these with their provider before starting either medication, as GLP-1 therapy can exacerbate them.

The key clinical insight is that most side effects are dose-dependent and transient. Slow dose escalation — which is standard protocol — dramatically reduces their severity.

How to Minimise Side Effects

1. Eat smaller, more frequent meals. Large meals exacerbate nausea and bloating when gastric emptying is slowed. Smaller portions across more meals reduce this significantly.

2. Avoid high-fat, greasy, or very spicy foods. These are the most common triggers for nausea and GI discomfort on GLP-1 therapy.

3. Stay well hydrated. Adequate hydration supports digestion and reduces constipation risk.

4. Do not rush dose escalation. If side effects are significant at a given dose, staying at that dose longer before escalating is clinically appropriate and produces better long-term tolerance.

5. Communicate with your provider. Side effects that are severe, persistent, or affecting quality of life should be discussed. Dose adjustment, timing changes, or supportive medications can help significantly.

Side Effects Are Manageable. Results Are Real.

The patients who navigate GLP-1 side effects best are the ones who know what to expect, make the right dietary adjustments, and have a provider they can talk to.

At HRT House, we do not hand you a prescription without preparing you for the experience of treatment. Our providers guide you through dose escalation, anticipate common challenges, and support you through every phase.

Book your consultation at hrthouse.com and start your GLP-1 journey with a team that will be with you every step of the way.

HRT House | Clearwater, FL & Miami, FL | hrthouse.com | +1 833 773 0414